Compounds > oxisuran
Page last updated: 2024-11-06

oxisuran

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

oxisuran: proposed antineoplastic & immunosuppressive agent; minor descriptor (75-86); on-line & INDEX MEDICUS search PYRIDINES (75-86) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID33770
CHEMBL ID2106596
SCHEMBL ID4657
MeSH IDM0263359

Synonyms (43)

Synonym
2-methylsulfinyl-1-(2-pyridyl)ethanone
2-(methylsulfinyl)-1-(2-pyridinyl)ethanone
pyridine, {2-[(methylsulfinyl)acetyl]-}
{2-[(methylsulfinyl)acetyl]pyridine}
oxisuran
2-[(methylsulfinyl)acetyl]pyridine
(methylsulfinyl)methyl 2-pyridyl ketone
ketone, (methylsulfinyl)methyl 2-pyridyl
pyridine, 2-[(methylsulfinyl)acetyl]-
ethanone, 2-(methylsulfinyl)-1-(2-pyridinyl)-
27302-90-5
w 6495
ismisupren
nsc-356716
nsc356716
ccris 489
oxisuranum [inn-latin]
2-((methylsulfinyl)acetyl)pyridine
oxisurano [inn-spanish]
oxisuran [usan:inn]
pyridine, 2-((methylsulfinyl)acetyl)-
brn 1526159
nsc 356716
oxisuran (usan/inn)
D05305
2-methylsulfinyl-1-pyridin-2-ylethanone
AKOS006271449
w-6495 ,
CHEMBL2106596
5-21-12-00151 (beilstein handbook reference)
njm3553dh2 ,
oxisuranum
oxisurano
unii-njm3553dh2
(+/-)-ethanone, 2-(methylsulfinyl)-1-(2-pyridinyl)-
oxisuran [usan]
oxisuran [inn]
SCHEMBL4657
SR-01000945003-1
sr-01000945003
Q27284895
DTXSID60865359
2-(methanesulfinyl)-1-(pyridin-2-yl)ethan-1-one
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
azathioprine
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed). azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.		1.9610aryl sulfide;
C-nitro compound;
imidazoles;
thiopurine		antimetabolite;
antineoplastic agent;
carcinogenic agent;
DNA synthesis inhibitor;
hepatotoxic agent;
immunosuppressive agent;
prodrug
cytarabine
[no description available]		1.9510beta-D-arabinoside;
monosaccharide derivative;
pyrimidine nucleoside		antimetabolite;
antineoplastic agent;
antiviral agent;
immunosuppressive agent
methotrexate
[no description available]		1.9610dicarboxylic acid;
monocarboxylic acid amide;
pteridines		abortifacient;
antimetabolite;
antineoplastic agent;
antirheumatic drug;
dermatologic drug;
DNA synthesis inhibitor;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
immunosuppressive agent
mercaptopurine
Mercaptopurine: An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia.. purine-6-thiol : A thiol that is the tautomer of mercaptopurine.. mercaptopurine : A member of the class of purines that is 6,7-dihydro-1H-purine carrying a thione group at position 6. An adenine analogue, it is used in the treatment of acute lymphocytic leukemia (ALL), chronic myeloid leukemia (CML), Crohn's disease, and ulcerative colitis.		1.9610aryl thiol;
purines;
thiocarbonyl compound		anticoronaviral agent;
antimetabolite;
antineoplastic agent
ConditionIndicatedRelationship StrengthStudiesTrials
Hemorrhagic Fever, American
Diseases caused by American hemorrhagic fever viruses (ARENAVIRUSES, NEW WORLD).		01.9510
Experimental Neoplasms
[description not available]		01.9610